Trial Profile
An open-label, randomized, multicenter study to evaluate the efficacy of the combination of valsartan and hydrochlorothiazide and amlodipine in hypertensive patients not controlled with valsartan and hydrochlorothiazide
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 26 Jun 2008
Price :
$35
*
At a glance
- Drugs Amlodipine (Primary) ; Hydrochlorothiazide (Primary) ; Valsartan (Primary)
- Indications Hypertension
- Focus Therapeutic Use
- Sponsors Novartis
- 17 Jun 2008 Status changed from in progress to completed as reported by ClinicalTrials.gov.
- 13 Aug 2007 Status changed from recruiting to in progress.
- 05 Dec 2006 New trial record.